Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/5/24 16:59 | 6/3/24 | PCVX | Health | BioPrd | Biological Products, (No Diag | Gilbert Halley E | CA | D | 1 | S.d | -1,329 | 73.00 | 0 | -18 | 6 | D | ||||||||||||||||
6/5/24 16:58 | 6/3/24 | PCVX | Health | BioPrd | Biological Products, (No Diag | Eydelman Mikhail | CA | O | SVP,GC,C | 3 | S.d | -334 | 66.84 | 0 | -5 | 31 | D | |||||||||||||||
6/5/24 16:57 | 6/3/24 | PCVX | Health | BioPrd | Biological Products, (No Diag | Wassil Jim | CA | O | COO | 3 | S | -601 | 66.77 | 0 | -9 | 218 | D | |||||||||||||||
6/5/24 16:56 | 6/3/24 | PCVX | Health | BioPrd | Biological Products, (No Diag | Pickering Grant | CA | DO | CEO | 5 | S.d | -2,457 | 64.92 | 0 | -38 | 775 | I | |||||||||||||||
5/22/24 17:03 | 5/20/24 | PCVX | Health | BioPrd | Biological Products, (No Diag | Guggenhime Andrew | CA | O | P,CFO | 3 | S.d | -1,642 | 68.43 | 0 | -24 | 96 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |